Schedule 13G ownership disclosure

MEREO BIOPHARMA GROUP PLC

American Depositary Shares, each representing five ordinary shares, nominal value of (pound)0.003 per share · CUSIP: 589492107

Event date: 2025-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Mangrove Partners IM, LLC

    Shares: 38,952,900.00 · Class: 4.9%

  • Nathaniel August

    Shares: 38,952,900.00 · Class: 4.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001172661-25-004855
Form type
SCHEDULE 13G/A
Filer
MANGROVE PARTNERS IM, LLC
CIK
CIK 1535392
Filed
Nov 14, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub